Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAN 2021 | Prevention of maternal antibody-mediated diseases

Angela Vincent • 8 Jun 2021
EAN 2021
Neuromuscular Disorders

Angela Vincent, MBBS (Hon PhD Bergen), FRCPath, FMedSci, FRS, University of Oxford, Oxford, UK, discusses the broad implications of using therapeutic monoclonal antibodies (mAbs) to prevent the trans-placental transfer of pathogenic antibodies in the prevention of maternal antibody-mediated diseases. New techniques and therapies are providing the opportunity for better research into these mechanisms. This interview took place during the European Academy of Neurology 2021 congress.

Disclosures

Prof. Vincent was a co-investigator on a small grant provided by UCB for the animal model work.

More from Angela Vincent

Therapeutic monoclonal antibodies to prevent trans-placental transfer of pathogenic antibodies
5:46
Therapeutic monoclonal antibodies to prevent trans-placental transfer of pathogenic antibodies
Angela Vincent • 8 Jun 2021
Why narcolepsy should not be considered an autoimmune disorder
7:19
Why narcolepsy should not be considered an autoimmune disorder
Angela Vincent • 30 Oct 2020
Revising the neuromyelitis optica criteria
4:39
Revising the neuromyelitis optica criteria
Angela Vincent • 30 Oct 2020

Related Videos

Challenges in the diagnosis of ALS: mimics and chameleons
3:08
Challenges in the diagnosis of ALS: mimics and chameleons
Mariam Kekenadze • 28 Jun 2026
Real-world insights into chronic inflammatory demyelinating polyneuropathy management
3:08
Real-world insights into chronic inflammatory demyelinating polyneuropathy management
Franz Felix Konen • 28 Jun 2026
The mechanisms underlying multifocal motor neuropathy
1:21
The mechanisms underlying multifocal motor neuropathy
Nicolas Dubuisson • 27 Jun 2026
Improving the transition to adult sleep care for young people with neuromuscular disorders
2:03
Improving the transition to adult sleep care for young people with neuromuscular disorders
Umakanth Katwa • 17 Jun 2026

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJNeurology is intended for healthcare professionals